[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) Paclitaxel Market Report 2017

November 2017 | 114 pages | ID: E8C49020F43EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Paclitaxel for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Paclitaxel market competition by top manufacturers/players, with Paclitaxel sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Phyton Biotech
  • ScinoPharm
  • Novasep
  • Samyang
  • Polymed
  • TAPI (Teva)
  • Fresenius-kabi
  • Southpharma
  • Haiyao
  • Huiang Biopharma
  • Yunnan Hande
  • Hainan Yew Pharm
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Natural Paclitaxel
  • Semi-synthetic Paclitaxel
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Paclitaxel Market Report 2017

1 PACLITAXEL OVERVIEW

1.1 Product Overview and Scope of Paclitaxel
1.2 Classification of Paclitaxel
  1.2.1 EMEA Paclitaxel Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Paclitaxel Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Natural Paclitaxel
  1.2.4 Semi-synthetic Paclitaxel
1.3 EMEA Paclitaxel Market by Application/End Users
  1.3.1 EMEA Paclitaxel Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Ovarian Cancer
  1.3.3 Cervical Cancer
  1.3.4 Breast Cancer
  1.3.5 Other
1.4 EMEA Paclitaxel Market by Region
  1.4.1 EMEA Paclitaxel Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Paclitaxel (2012-2022)
  1.5.1 EMEA Paclitaxel Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Paclitaxel Revenue and Growth Rate (2012-2022)

2 EMEA PACLITAXEL COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Paclitaxel Market Competition by Players/Manufacturers
  2.1.1 EMEA Paclitaxel Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Paclitaxel Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Paclitaxel Sale Price by Players (2012-2017)
2.2 EMEA Paclitaxel (Volume and Value) by Type/Product Category
  2.2.1 EMEA Paclitaxel Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Paclitaxel Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Paclitaxel Sale Price by Type (2012-2017)
2.3 EMEA Paclitaxel (Volume) by Application
2.4 EMEA Paclitaxel (Volume and Value) by Region
  2.4.1 EMEA Paclitaxel Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Paclitaxel Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Paclitaxel Sales Price by Region (2012-2017)

3 EUROPE PACLITAXEL (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Paclitaxel Sales and Value (2012-2017)
  3.1.1 Europe Paclitaxel Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Paclitaxel Revenue and Growth Rate (2012-2017)
3.2 Europe Paclitaxel Sales and Market Share by Type
3.3 Europe Paclitaxel Sales and Market Share by Application
3.4 Europe Paclitaxel Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Paclitaxel Sales Volume by Countries (2012-2017)
  3.4.2 Europe Paclitaxel Revenue by Countries (2012-2017)
  3.4.3 Germany Paclitaxel Sales and Growth Rate (2012-2017)
  3.4.4 France Paclitaxel Sales and Growth Rate (2012-2017)
  3.4.5 UK Paclitaxel Sales and Growth Rate (2012-2017)
  3.4.6 Russia Paclitaxel Sales and Growth Rate (2012-2017)
  3.4.7 Italy Paclitaxel Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Paclitaxel Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PACLITAXEL (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Paclitaxel Sales and Value (2012-2017)
  4.1.1 Middle East Paclitaxel Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Paclitaxel Revenue and Growth Rate (2012-2017)
4.2 Middle East Paclitaxel Sales and Market Share by Type
4.3 Middle East Paclitaxel Sales and Market Share by Application
4.4 Middle East Paclitaxel Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Paclitaxel Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Paclitaxel Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Paclitaxel Sales and Growth Rate (2012-2017)
  4.4.4 Israel Paclitaxel Sales and Growth Rate (2012-2017)
  4.4.5 UAE Paclitaxel Sales and Growth Rate (2012-2017)
  4.4.6 Iran Paclitaxel Sales and Growth Rate (2012-2017)

5 AFRICA PACLITAXEL (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Paclitaxel Sales and Value (2012-2017)
  5.1.1 Africa Paclitaxel Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Paclitaxel Revenue and Growth Rate (2012-2017)
5.2 Africa Paclitaxel Sales and Market Share by Type
5.3 Africa Paclitaxel Sales and Market Share by Application
5.4 Africa Paclitaxel Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Paclitaxel Sales Volume by Countries (2012-2017)
  5.4.2 Africa Paclitaxel Revenue by Countries (2012-2017)
  5.4.3 South Africa Paclitaxel Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Paclitaxel Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Paclitaxel Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Paclitaxel Sales and Growth Rate (2012-2017)

6 EMEA PACLITAXEL MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Phyton Biotech
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Paclitaxel Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Phyton Biotech Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 ScinoPharm
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Paclitaxel Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novasep
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Paclitaxel Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Samyang
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Paclitaxel Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Polymed
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Paclitaxel Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 TAPI (Teva)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Paclitaxel Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Fresenius-kabi
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Paclitaxel Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Southpharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Paclitaxel Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Haiyao
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Paclitaxel Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Haiyao Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Huiang Biopharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Paclitaxel Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Huiang Biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Yunnan Hande
6.12 Hainan Yew Pharm

7 PACLITAXEL MANUFACTURING COST ANALYSIS

7.1 Paclitaxel Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Paclitaxel

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Paclitaxel Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Paclitaxel Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PACLITAXEL MARKET FORECAST (2017-2022)

11.1 EMEA Paclitaxel Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Paclitaxel Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Paclitaxel Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Paclitaxel Price and Trend Forecast (2017-2022)
11.2 EMEA Paclitaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Paclitaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Paclitaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Paclitaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Paclitaxel Sales Forecast by Type (2017-2022)
11.7 EMEA Paclitaxel Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Paclitaxel
Figure EMEA Paclitaxel Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Paclitaxel Sales Volume Market Share by Type (Product Category) in 2016
Figure Natural Paclitaxel Product Picture
Figure Semi-synthetic Paclitaxel Product Picture
Figure EMEA Paclitaxel Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Paclitaxel by Application in 2016
Figure Ovarian Cancer Examples
Table Key Downstream Customer in Ovarian Cancer
Figure Cervical Cancer Examples
Table Key Downstream Customer in Cervical Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Paclitaxel Market Size (Million USD) by Region (2012-2022)
Figure Europe Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Paclitaxel Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Paclitaxel Revenue (Million USD) Status and Forecast by Countries
Figure Africa Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Paclitaxel Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Paclitaxel Sales Volume and Growth Rate (2012-2022)
Figure EMEA Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Paclitaxel Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Paclitaxel Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Paclitaxel Sales Share by Players (2012-2017)
Figure 2016 Paclitaxel Sales Share by Players
Figure 2017 Paclitaxel Sales Share by Players
Figure EMEA Paclitaxel Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Paclitaxel Revenue (Million USD) by Players (2012-2017)
Table EMEA Paclitaxel Revenue Share by Players (2012-2017)
Table 2016 EMEA Paclitaxel Revenue Share by Players
Table 2017 EMEA Paclitaxel Revenue Share by Players
Table EMEA Paclitaxel Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Paclitaxel Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Paclitaxel Sales Share by Type (2012-2017)
Figure Sales Market Share of Paclitaxel by Type (2012-2017)
Figure EMEA Paclitaxel Sales Market Share by Type (2012-2017)
Table EMEA Paclitaxel Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Paclitaxel Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Paclitaxel by Type in 2016
Table EMEA Paclitaxel Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Paclitaxel Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Paclitaxel Sales Share by Application (2012-2017)
Figure Sales Market Share of Paclitaxel by Application (2012-2017)
Figure EMEA Paclitaxel Sales Market Share by Application in 2016
Table EMEA Paclitaxel Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Paclitaxel Sales Share by Region (2012-2017)
Figure Sales Market Share of Paclitaxel by Region (2012-2017)
Figure EMEA Paclitaxel Sales Market Share in 2016
Table EMEA Paclitaxel Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Paclitaxel Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Paclitaxel by Region (2012-2017)
Figure EMEA Paclitaxel Revenue Market Share Regions in 2016
Table EMEA Paclitaxel Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Paclitaxel Revenue and Growth Rate (2012-2017)
Table Europe Paclitaxel Sales (K MT) by Type (2012-2017)
Table Europe Paclitaxel Market Share by Type (2012-2017)
Figure Europe Paclitaxel Market Share by Type in 2016
Table Europe Paclitaxel Sales (K MT) by Application (2012-2017)
Table Europe Paclitaxel Market Share by Application (2012-2017)
Figure Europe Paclitaxel Market Share by Application in 2016
Table Europe Paclitaxel Sales (K MT) by Countries (2012-2017)
Table Europe Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Europe Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Europe Paclitaxel Sales Market Share by Countries in 2016
Table Europe Paclitaxel Revenue (Million USD) by Countries (2012-2017)
Table Europe Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Europe Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Europe Paclitaxel Revenue Market Share by Countries in 2016
Figure Germany Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure France Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure UK Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Paclitaxel Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Paclitaxel Sales (K MT) by Type (2012-2017)
Table Middle East Paclitaxel Market Share by Type (2012-2017)
Figure Middle East Paclitaxel Market Share by Type (2012-2017)
Table Middle East Paclitaxel Sales (K MT) by Applications (2012-2017)
Table Middle East Paclitaxel Market Share by Applications (2012-2017)
Figure Middle East Paclitaxel Sales Market Share by Application in 2016
Table Middle East Paclitaxel Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Paclitaxel Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Paclitaxel Sales Volume Market Share by Countries in 2016
Table Middle East Paclitaxel Revenue (Million USD) by Countries (2012-2017)
Table Middle East Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Middle East Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Middle East Paclitaxel Revenue Market Share by Countries in 2016
Figure Saudi Arabia Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Paclitaxel Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Paclitaxel Sales (K MT) by Type (2012-2017)
Table Africa Paclitaxel Sales Market Share by Type (2012-2017)
Figure Africa Paclitaxel Sales Market Share by Type (2012-2017)
Figure Africa Paclitaxel Sales Market Share by Type in 2016
Table Africa Paclitaxel Sales (K MT) by Application (2012-2017)
Table Africa Paclitaxel Sales Market Share by Application (2012-2017)
Figure Africa Paclitaxel Sales Market Share by Application (2012-2017)
Table Africa Paclitaxel Sales Volume (K MT) by Countries (2012-2017)
Table Africa Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Africa Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Africa Paclitaxel Sales Market Share by Countries in 2016
Table Africa Paclitaxel Revenue (Million USD) by Countries (2012-2017)
Table Africa Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Africa Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Africa Paclitaxel Revenue Market Share by Countries in 2016
Figure South Africa Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Table Phyton Biotech Paclitaxel Basic Information List
Table Phyton Biotech Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Phyton Biotech Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Phyton Biotech Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Phyton Biotech Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table ScinoPharm Paclitaxel Basic Information List
Table ScinoPharm Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure ScinoPharm Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure ScinoPharm Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure ScinoPharm Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Novasep Paclitaxel Basic Information List
Table Novasep Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novasep Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Novasep Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Novasep Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Samyang Paclitaxel Basic Information List
Table Samyang Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Samyang Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Samyang Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Samyang Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Polymed Paclitaxel Basic Information List
Table Polymed Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Polymed Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Polymed Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Polymed Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table TAPI (Teva) Paclitaxel Basic Information List
Table TAPI (Teva) Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure TAPI (Teva) Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure TAPI (Teva) Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure TAPI (Teva) Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Fresenius-kabi Paclitaxel Basic Information List
Table Fresenius-kabi Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Fresenius-kabi Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Fresenius-kabi Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Fresenius-kabi Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Southpharma Paclitaxel Basic Information List
Table Southpharma Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Southpharma Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Southpharma Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Southpharma Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Haiyao Paclitaxel Basic Information List
Table Haiyao Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Haiyao Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Haiyao Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Haiyao Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Huiang Biopharma Paclitaxel Basic Information List
Table Huiang Biopharma Paclitaxel Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Huiang Biopharma Paclitaxel Sales (K MT) and Growth Rate (2012-2017)
Figure Huiang Biopharma Paclitaxel Sales Market Share in EMEA (2012-2017)
Figure Huiang Biopharma Paclitaxel Revenue Market Share in EMEA (2012-2017)
Table Yunnan Hande Paclitaxel Basic Information List
Table Hainan Yew Pharm Paclitaxel Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Paclitaxel
Figure Manufacturing Process Analysis of Paclitaxel
Figure Paclitaxel Industrial Chain Analysis
Table Raw Materials Sources of Paclitaxel Major Manufacturers in 2016
Table Major Buyers of Paclitaxel
Table Distributors/Traders List
Figure EMEA Paclitaxel Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Paclitaxel Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Paclitaxel Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Paclitaxel Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Paclitaxel Sales Market Share Forecast by Region (2017-2022)
Table EMEA Paclitaxel Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Paclitaxel Revenue Market Share Forecast by Region (2017-2022)
Table Europe Paclitaxel Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Paclitaxel Sales Market Share Forecast by Countries (2017-2022)
Table Europe Paclitaxel Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Paclitaxel Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Paclitaxel Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Paclitaxel Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Paclitaxel Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Paclitaxel Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Paclitaxel Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Paclitaxel Sales Market Share Forecast by Countries (2017-2022)
Table Africa Paclitaxel Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Paclitaxel Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Paclitaxel Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Paclitaxel Sales Market Share Forecast by Type (2017-2022)
Table EMEA Paclitaxel Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Paclitaxel Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications